Aptorum Group Files Latest S-4 Amendment for DiamiR Reverse Merger, Details Shareholder Vote on Dilutive Proposals
APM sits 30% above its 52-week low of $0.65.
Summary
Aptorum Group filed its latest S-4 amendment, detailing the upcoming shareholder vote on a reverse merger with DiamiR Biosciences, which includes a reverse stock split and significant dilution for current shareholders, as the company seeks to address its going concern status and maintain its Nasdaq listing.
Key Events · M&A and Partnerships · APM
-
Reverse Merger Update
This Pre-Effective Amendment No. 4 to the S-4 filing details the proposed reverse merger with DiamiR Biosciences, where DiamiR stockholders will own approximately 70% of the combined company, and existing Aptorum shareholders 30%.
-
Shareholder Vote Scheduled
A Special Meeting on June 9, 2026, will address proposals including a reverse stock split (at a ratio between 1:2 and 1:10), domestication to Delaware, issuance of shares for the merger, and a new 4.5 million share incentive plan.
-
Guaranteed Approval
CEO Ian Huen, holding 86.71% of Aptorum's total voting power, has signed an agreement to vote in favor of all proposals, ensuring their approval without the need for other shareholder votes.
-
Going Concern & Nasdaq Compliance
The company's auditor has expressed substantial doubt about its ability to continue as a going concern, and the proposed reverse stock split is intended to help meet Nasdaq's minimum bid price requirement for continued listing.
Analysis · APM · Industrial Applications And Services
This filing provides the latest comprehensive details for Aptorum Group's proposed reverse merger with DiamiR Biosciences, including critical shareholder proposals for a reverse stock split, domestication to Delaware, and the issuance of shares that will result in existing Aptorum shareholders owning only 30% of the combined entity. The company continues to operate under a going concern warning, making this merger a crucial, albeit highly dilutive, path for its survival and continued Nasdaq listing. The CEO's controlling vote ensures all proposals will pass.
At the time of this filing, APM was trading at $0.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.9M. The 52-week trading range was $0.65 to $4.47. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.